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Mast cells are inﬂammatory cells that respond to signals of innate and adaptive immunity with immedi-
ate and delayed release of mediators. ArtinM, a lectin from Artocarpus integrifolia with immunomodula-
tory activities, is able to induce mast cell activation, but the mechanisms remain unknown. This study
sought to further investigate the effects of the lectin on mast cells. We showed that ArtinM binds to mast
cells, possibly to the high afﬁnity receptor for immunoglobulin E (IgE) – FceRI – and/or to IgE bound to
FceRI. Binding of the lectin resulted in protein tyrosine phosphorylation and release of the pre- and
newly-formed mediators, b-hexosaminidase and LTB4 by mast cells, activities that were potentiated in
the presence of IgE. ArtinM also induced the activation of the transcription factors NFjB and NFAT, result-
ing in expression of some of their target genes such as IL-4 and TNF-a. In view of the established signif-
icance of mast cells in many immunological and inﬂammatory reactions, a better understanding of the
mechanisms involved in mast cell activation by ArtinM is crucial to the pharmacological application of
the lectin.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Mast cells arehematopoieticallyderived, tissue-localized inﬂam-
matory cells that respond to signals of innate and adaptive immu-
nity with immediate and delayed release of inﬂammatory
mediators. Mast cells are central to the pathogenesis of immediate
hypersensitivity diseases, andmediate tissue responses, fulﬁll effec-
tor and immunoregulatory functions and are implicated in tissue
remodeling [1].
The major pathway for mast cell activation is through the high-
afﬁnity receptor for immunoglobulin E (FceRI). FceRI-dependent
mast cell activation includes the rapid release of cytoplasmic gran-
ule-associatedmediators, the secretion of de novo-synthesized lipid
mediators as well as the synthesis and release of chemokines, and
growth factors [2].
Lectins are included among the molecules that induce mast cell
activation [3]. Results obtained by our group showed that ArtinM, a
structurally well deﬁned D-mannose-binding lectin from Artocarpus
integrifolia [4], is able to induce the recruitment of rat mast cells
from the bone marrow to the peritoneal cavity [5] and degranulate
rat peritoneal mast cells [6].de Enfermagem Materno-
de Ribeirão Preto/USP, Av.
zil. Fax: +55 16 36020518.
-Silva).
lsevier OA license.Several functions have been described for ArtinM, including
immunomodulatory activity [7,8]. The lectin induces IL-12 produc-
tion by macrophages [7], which confers resistance to infections by
intracellular pathogens [7,9]. In addition, ArtinM induces neutrophil
migrationmediated by the simultaneous interaction of its carbohy-
drate recognitiondomains (CRDs)with cell surface and extracellular
matrix N-glycans [10]. An ampliﬁcation of the neutrophil recruit-
ment induced by ArtinM is provided by mast cell degranulation
[6]. Moreover, ArtinM is able to accelerate the process of wound
healing and epithelial tissue regeneration [11].
Due to the potential pharmaceutical applications of ArtinM and
the role of mast cells in diverse immunological and inﬂammatory
reactions, this study sought to further investigate the effects of the
lectinonmast cells. Themechanisms involved inmast cell activation
by ArtinM were examined. Our results demonstrate that ArtinM
binds to mast cells, possibly through cell-bound IgE and/or FceRI,
leading to cell activation and release of mediators.
2. Materials and methods
2.1. ArtinM preparations
ArtinM was extracted from A. integrifolia seeds and puriﬁed
by sugar afﬁnity chromatography as described [4]. The protein
concentration was determined by Bradford assay (Bio-Rad Labora-
tories, Inc., Canada). Biotinylation of ArtinM was performed as
previously described [11].
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The rat mast cell line, RBL-2H3, was grown as monolayers as
previously described [12]. The RBL-2H3 NFAT-GFP and the RBL-
2H3 NFjB-GFP cell lines, produced as described [13], were kindly
provided by Dr. Reuben Siraganian.2.3. Cell sensitization and stimulation
RBL-2H3 cells were cultured overnight (ON) in the presence or
absence of a 1:5000 dilution of mouse IgE anti-TNP ascites ﬂuid.
The cells were then incubated with 10 lg/ml of ArtinM for different
times, as indicated. As a positive control, cells were sensitized with
anti-TNP IgE and then stimulated with 50 ng/ml of DNP48-HSA
(Sigma–Aldrich). Cells that were not sensitizedwith IgE or not stim-
ulated with DNP48-HSA were used as negative controls.
2.4. Antibodies
The following primary antibodies were used: a pool of three
mouse mAbs, BE2AB6, BE3D2, and BE5D1 (mAb BEs) [14] to the
FceRI b subunit, (1 lg/ml), and mAb 4G10-HRP conjugate (0.5 lg/
ml, Millipore Corporation, Bedford, MA) against phosphotyrosine.
Donkey anti-mouse IgG-HRP, (0.04 lg/ml; Jackson ImmunoRe-
search, USA) was used as the secondary antibody.
2.5. ArtinM binding to RBL-2H3 cell surface
2.5.1. Flow cytometry
1  106 cells were incubated with biotinylated ArtinM (1.25–
10.0 lg/ml) for 1 h at 4 C. In some assays, the lectin was pre-
incubated with 50 mM D-mannose (Sigma–Aldrich, St. Louis, MO,
USA) or D-galactose (Sigma–Aldrich) for 1 h at 4 C. After incuba-
tion with streptavidin-FITC (1:4000) (Sigma–Aldrich) for 30 min
at 4 C, cells were washed in PBS, ﬁxed for 20 min with 2% formal-
dehyde (EM Sciences, USA) and analyzed with a BD FACS Calibur™
ﬂow cytometer, using the CellQuest program (Becton–Dickinson
Labware, USA).
2.5.2. Confocal microscopy
5  104 cells were cultured ON on coverslips and then incu-
bated with biotinylated ArtinM (10 lg/ml) for 1 h at 4 C. In some
assays, the lectin was pre-incubated with 50 mM D-mannose or
D-galactose (Sigma–Aldrich) for 1 h at 4 C. The cells were ﬁxed
with 2% formaldehyde (EM Sciences) at RT for 20 min, washed in
PBS and incubated with 5 lg/ml streptavidin-FITC (Jackson Immu-
noResearch Laboratories, Inc., USA) at RT for 30 min. Then the cells
were washed in PBS and rinsed in distilled water. The cover slips
were mounted on slides with Fluormount-G (EM Sciences) and
examined with a LEICA TCS-SP2 scanning confocal microscope
(Leica Microsystems, Germany).
2.6. ArtinM binding to IgE
ArtinM (2.5–30 lg/ml), which in some assays was pre-incu-
bated with 25 and 50 mM D-mannose (Sigma–Aldrich) for 1 h at
4 C, was added to IgE-coated wells (1 mg/ml, rat IgE – Biosource,
International, USA). The assay was performed as described [10]
and binding was assessed by reading the absorbance at 450 nm
(Power Wave X, Bio-Tek Instruments, Inc., USA).
2.7. ArtinM binding to FceRI and tyrosine phosphorylation
IgE-sensitized or unsensitized cells were incubated for 15 min
with ArtinM or DNP48-HSA in DMEM. Total cell lysates wereobtained as described [15]. The proteinswere separated electropho-
retically on 10% polyacrylamide gels under reducing conditions (3%
b-mercaptoethanol – Sigma–Aldrich) and transferred to Hybond
membranes (GEHealthcare Biosciences, USA). Themembraneswere
blocked for 16 h at 4 C in TTBS buffer containing 4% BSA and incu-
bated for 1 h at RT with mAb BEs or with biotinylated ArtinM, or
mAb 4G10-HRP. For FceRI binding assays, the membranes were
incubated with anti-mouse IgG-HRP secondary antibody or strepta-
vidin-HRP for 30 min. Themembraneswere developedusing chemi-
luminescence (ECL-GE Healthcare Biosciences). For stripping, the
ﬁrst immunoblot was immersed in stripping buffer (62.5 mM
Tris–HCl, pH 6.8, 2% SDS, and 10 mM b-mercaptoethanol) for 1 h at
56 C and the immunoblot was repeated as described. For quantiﬁ-
cation of tyrosine phosphorylation levels, optical densitywas deter-
mined using Photoshop 7.0 (Adobe Systems Incorporated, USA).
2.8. b-Hexosaminidase activity
IgE-sensitized or unsensitized cells were incubated for 45 min
with ArtinM or DNP48-HSA in Tyrode’s buffer. In some assays,
ArtinMwas pre-incubatedwith 50 mMD-mannose (Sigma–Aldrich)
for 1 h at 4 C. Degranulation of RBL-2H3 cells was assessed bymea-
suring the release of b-hexosaminidase activity [16].
2.9. Leukotriene B4 and cytokine detection assays
IgE-sensitized or unsensitized cells were incubated for different
times with ArtinM or DNP48-HSA in DMEM. The concentrations of
LTB4, TNF-a and IL-4 in cell culture supernatants were measured
by ELISA (Leukotriene B4 EIA kit, Cayman Chemical Company, MI,
USA; OPTEIA™ Rat TNF ELISA kit II; OPTEIA™ Rat IL-4 ELISA kit II
– BD Biosciences) according to the manufacturer’s instructions.
2.10. Flow cytometric measurements of NFAT and NFjB activation
GFP reporter was used as a marker of FceRI-induced NFAT or
NFjB activation. IgE-sensitized or nonsensitized cells were stimu-
lated with ArtinM or DNP48-HSA for 20 h (for NFAT activity) or 5 h
(forNFjBactivity). Theseperiodsof stimulationwere found to result
in maximal GFP expression. Fluorescence levels were measured
using a Guava Personal Cell Analysis-96 System and data were pro-
cessed by Guava InCyte Software (Millipore).
3. Results
3.1. Binding of ArtinM to mast cell surface occurs via CRDs
To study the binding of ArtinM to ligands on the surface of mast
cells, RBL-2H3 cells were incubated with biotinylated ArtinM
(1.25–10 lg/ml) and analyzed by ﬂow cytometry. As shown in
Fig. 1A, maximum binding of ArtinM to the cell surface was ob-
served with 10 lg/ml of the lectin, where 97% of the mast cells
were labeled. Inhibition of lectin binding by the speciﬁc sugar
was assayed by ﬂow cytometry and confocal microscopy. Flow
cytometric analysis showed that ArtinM (10 lg/ml) binding to
RBL-2H3 cells was abolished in the presence of D-mannose
(50 mM), whereas D-galactose (50 mM) had no effect on binding
(Fig. 1B). By confocal microscopy, ArtinM (10 lg/ml) was evenly
distributed on the surface of mast cells. Binding of the lectin was
inhibited in the presence of D-mannose, but not D-galactose
(Fig. 1C). These results indicate that ArtinM binds to the mast cell
surface via CRDs.
3.2. ArtinM binds to IgE via CRDs and to FceRI
As previously demonstrated [6], ArtinM is able to bind to IgE.
Since the N-linked oligosaccharides present on IgE are potential
Fig. 1. ArtinM binds to the surface of mast cells via carbohydrate recognition domains. 1  106 cells were incubated with biotinylated ArtinM (1.25–10.0 lg/ml) for 1 h at 4 C
(A). ArtinM (10 lg/ml) was previously incubated, for 1 h at 4 C, with 50 mM D-mannose or D-galactose (B). Cells were ﬁxed, incubated with streptavidin-FITC and analyzed by
FACS. Data are representative of three independent experiments. 5  104 cells were allowed to adhere to coverslips and were incubated with biotinylated ArtinM (10 lg/ml)
for 1 h at 4 C. In some assays, ArtinM was pre-incubated with 50 mM D-mannose or D-galactose. Cells were ﬁxed, incubated with streptavidin-FITC and examined by confocal
and DIC microscopy (C).
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binding to the immunoglobulin occurs via CRDs of the lectin. We
performed a microplate binding assay using biotinylated ArtinM
(2.5–30.0 lg/ml) and also tested binding inhibition by D-mannose
(Fig. 2). There was a signiﬁcant increase in ArtinM binding between
2.5 and 5 lg/ml and a further increase at 10 lg/ml. There was no
further increase in the binding after 10 lg/ml (Fig. 2A). Thus,
10 lg/ml of ArtinM was used in inhibition binding assays. ArtinM
binding to IgE was reduced by 68% and 83% respectively when
the lectin was previously incubated with 25 and 50 mM of
D-mannose (Fig. 2B).
Structural features of FceRI favor its recognition by lectins and
so we investigated whether ArtinM would bind to the receptor.
Total cell lysates immunoblotted with mAb BEs that recognize
the b subunit of FceRI, as well as those blotted with biotinylated
ArtinM were compared. Among the various protein bands recog-
nized by the lectin, the one with a molecular weight around
35 kDa was coincident to that recognized by the BEs (Fig. 2C and
D). After stripping the membrane and reprobing with ArtinM, the
same 35 kDa band was recognized by the lectin. The same was ob-
served when the membrane incubated with ArtinM was stripped
and reprobed with BEs (not shown).These results indicate that ArtinM binds to IgE through its CRDs
and possibly binds to the b-subunit of FceRI expressed on mast
cells.
3.3. ArtinM induces IgE mediated tyrosine phosphorylation and
mediator release
Since ArtinM binds to FceRI we therefore evaluated the ability
of the lectin to stimulate tyrosine phosphorylation. RBL-2H3 cells
were sensitized with anti-TNP IgE followed by stimulation with
ArtinM or DNP48-HSA. Similar to the response triggered by antigen
induced FceRI activation, increased levels of tyrosine phosphoryla-
tion were detected in IgE-sensitized cells upon stimulation with
ArtinM (Fig. 3A). Indeed, there was an increase of approximately
50% in phosphotyrosine levels when IgE-sensitized cells were stim-
ulated either with ArtinM or DNP48-HSA (Fig. 3B).
The ability of ArtinM to induce degranulation of RBL-2H3 cells
was investigated by b-hexosaminidase release assays. b-hexosa-
minidase activity in the supernatant by ArtinM-stimulated cells
almost doubled in the presence of IgE, exceeding the values ob-
served with antigen induced FceRI activation (Fig. 3C). The produc-
tion of the newly formed mediator leukotriene B4 by mast cells in
Fig. 2. ArtinM binds to IgE and to FceRI. Biotinylated ArtinM (2.5–30.0 lg/ml) was incubated in IgE-coated (1 mg/ml) microwell plates for 2 h at RT (A). ArtinM (10 lg/ml)
was pre-incubated with 25 or 50 mM D-mannose (B). After incubation with streptavidin-HRP and development with TMB, ArtinM binding to IgE was assessed by reading the
optical density at 450 nm. The value provided by 10 lg/ml of ArtinM was considered as 100% of binding. Data represent the mean of three different experiments ± SD.
⁄p < 0.05 between ArtinM and samples incubated with D-mannose. Cell lysates were separated on a 10% SDS–PAGE gels and analyzed by blotting with biotinylated ArtinM (C)
or with antibody against the b-subunit of FceRI (D). Blots are representative of four independent experiments.
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ence of IgE, the lectin induced the release of LTB4 at levels similar
to those detected when cells were stimulated through FceRI.
ArtinM alone did not induce LTB4 release (Fig. 3D). The release of
pre-formed and newly formed mediators induced by ArtinM was
inhibited by pre-incubation of the lectin with D-mannose (not
shown).
These results indicate that ArtinM activates IgE-sensitized RBL-
2H3 cells, inducing protein tyrosine phosphorylation, and that
ArtinM-induced release of the b-hexosaminidase and LTB4 is
potentiated by IgE.
3.4. ArtinM induces the activation of transcriptions factors and the
expression of target genes
Since ArtinM triggers intracellular signaling in mast cells, we
investigated whether transcription factors were activated. Initially,
IgE-sensitized or non-sensitized RBL-2H3 cells transfected with
NFjB- or NFAT-GFP were stimulated with ArtinM and then exam-
ined by ﬂow cytometry for expression of NFjB-GFP and NFAT-GFP.
As shown in Fig. 4A and B, ArtinM activated both NFAT and NFjB in
the presence and in the absence of IgE.
We also observed that the activation of NFjB and NFAT was cor-
related with the expression of their target genes. In IgE-sensitizedcells ArtinM stimulation led to an increased production of TNF-a
and IL-4, whose synthesis is mediated by activation of NFAT and
NFjB, respectively (Fig. 4C and D). These results indicate that
ArtinM induces the activation of NFjB and NFAT, resulting in
expression of some of their target genes.4. Discussion
The present study demonstrates that mast cell activation in-
duced by ArtinM culminates in degranulation and mediator re-
lease, activities that are signiﬁcantly increased in the presence of
IgE. Furthermore, our results indicate that the high afﬁnity recep-
tor for IgE and/or the IgE bound to FceRI are candidate ligands
for the lectin on the mast cell surface.
Previous studies from our group demonstrated that ArtinM
binds to rat peritoneal mast cells, inducing degranulation of these
cells [6]. In the current investigation we demonstrated that ArtinM
binding to mast cells occurs via CRDs of the lectin, since ArtinM
binding to RBL-2H3 cells was strongly inhibited by D-mannose.
Both IgE and FceRI are glycosylated and thus are potential tar-
gets for recognition by lectins. Previous studies have reported bind-
ing of lectins to IgE [7,21–23] and to FceRI [17]. Galectin-3, in turn,
binds to both IgE and FceRI [18–20]. Our results demonstrate that
Fig. 3. ArtinM induces protein tyrosine phosphorylation and the release of b-hexosaminidase and leukotriene B4 by mast cells. IgE-sensitized or unsensitized RBL-2H3 cells
were stimulated with ArtinM (10 lg/ml) or DNP48-HSA (50 ng/ml) for 15 min. Cell lysates were separated on a 10% SDS–PAGE gel and analyzed by blotting with anti-
phosphotyrosine-HRP (A). A is representative of three independent experiments and B represents the mean of three different experiments ± SD. IgE-sensitized or unsentitized
RBL-2H3 cells were stimulated with ArtinM (10 lg/ml) for 45 and 30 min and release of b-hexosaminidase activity (C) and LTB4 (D) in the culture supernatant was
determined, respectively. Data are expressed as mean ± SD and are representative of three different experiments. ⁄p < 0.05 between samples and the control.
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has 7N-linked glycosylation sites [21] and the Asn-394 of this chain
is occupied by oligomannose structures [21,22]. This pattern of gly-
cosylation may explain the binding of ArtinM to IgE. Furthermore,
binding of the lectin was inhibited by D-mannose. FceRI belongs
to the multichain immune receptor superfamily [23]. Among the
subunits of this receptor, only the a-subunit is N-glycosylated
[24]. We observed that ArtinM does not bind to this subunit (not
shown), but instead it binds to the b-subunit of FceRI, a chain that
is not directly involved in binding to IgE.
Each of the subunits of the FceRI has an individual function. The
a-chain is involved in IgE binding while the b- and c-chains are in-
volved in signal transduction [25]. Upon aggregation of FceRI, the
tyrosine residues in the ITAMs of the b- and c-chains are phosphor-
ylated by the action of receptor-associated tyrosine kinases of the
Src family (PTKs), which allows it to be bound by the Src homology
2 domains present in a number of signaling molecules [26]. The
activated PTKs phosphorylate diverse signaling molecules. This
activation ultimately culminates in degranulation, the de novo syn-
thesis of proinﬂammatory lipid mediators and the synthesis and
secretion of cytokines [27]. Thus, activation of tyrosine kinases iscentral to the ability of FceRI to transmit downstream signaling
events required for the regulation of mast cell activation [28].
In this study, exposure to ArtinM resulted in tyrosine phosphor-
ylation of proteins in IgE-sensitized mast cells, suggesting that
ArtinM binds to IgE bound to FceRI, inducing crosslinking of the
receptor and triggering signal transduction. Lectin binding to mast
cells also resulted in degranulation, in the presence and in the ab-
sence of IgE. In the presence of IgE, however, the release of
b-hexosaminidase almost doubled. These ﬁndings conﬁrm the abil-
ity of ArtinM to activate either unsensitized or IgE sensitized mast
cells [6] and are in agreement with our results that demonstrate
that the lectin binds to IgE and to the FceRI. In both cases, binding
of ArtinM may result in FceRI aggregation, thus inducing mast cell
degranulation. It is plausible that binding of the lectin directly to
FceRI or to IgE bound to FceRI determine quantitatively and/or
qualitatively different cell responses. We speculate that in the
presence of IgE, ArtinM could induce extensive crosslinking of
the receptors, thereby resulting in increased phosphorylation of
FceRI and further downstream signaling. As observed for phos-
phorylation of proteins induced by ArtinM, the production of leu-
kotriene B4 in response to ArtinM also occurred only when the
Fig. 4. ArtinM activates the transcription factors NFAT and NFjB and induces the release of TNF-a and IL-4. IgE-sensitized or unsentitized NFjB and NFAT-GFP transfected
RBL-2H3 cells were stimulated with ArtinM (10 lg/ml) or DNP48-HSA (50 ng/ml). Cells were analysed by ﬂow cytometry for NFAT (A) and NFjB (B) driven GFP expression.
IgE-sensitized or unsensitized RBL-2H3 cells were stimulated with ArtinM (10 lg/ml), the supernatants were collected and concentrations of TNF-a (C) and IL-4 (D) measured
by ELISA. Data are expressed as mean ± SD and are representative of three different experiments. ⁄p < 0.05 between the experimental samples and the control.
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strated that the duration and the magnitude of the signal through
FceRI indeed determine different mast cell responses [29,30].
Receptor stimulation ultimately results in activation of speciﬁc
genes encoding cytokines and growth factors, which may be medi-
ated bymembers of the NFAT and/or NFjB transcription factor fam-
ilies [31]. As shown in this study, ArtinM stimulation led to the
activation of NFAT and NFjB, inducing expression of some of their
target genes such as TNF-a and IL-4, respectively. Although ArtinM-
induced activation of transcription factors occurred whether cells
were sensitized or not with IgE, the release of cytokines required
previous sensitization. Recently, it has been reported that FceRI
activation can indeed result in nuclear signaling, as shown by NFAT
activation, in the absence of mediator release [13]. Again, our ﬁnd-
ings suggest that different mast cell responses are the result of dif-
ferences in signaling triggered by binding of ArtinM to FceRI or to
IgE bound to FceRI. However, whether such bindings are inter-
preted by FceRI as quantitative differences and are converted into
qualitatively distinct outputs through respective signaling path-
ways remains to be investigated.
In conclusion, our results suggest that ArtinM, whether interact-
ing with speciﬁc carbohydrates on cell-bound IgE or directly with
FceRI, activates mast cells, inducing degranulation and synthesis
of newly formed lipid mediators and cytokines. In view of the
well-established signiﬁcance of mast cells in many immunologicaland inﬂammatory reactions, a better understanding of the mecha-
nisms involved in mast cell activation by ArtinM is crucial to the
pharmacological application of the lectin.
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